Expression patterns of WT-1 and Bcr-Abl measured by TaqMan quantitative real-time RT-PCR during follow-up of leukemia patients with the Ph chromosome

Chinese Medical Journal

Volumn 117, Issue 7, 2004, Pages 968-971

  Chen, Zi Xing ^a   Kaeda, Jaspal ^b   Saunders, Sue ^b   Goldman, John M ^b  

^a SOOCHOW UNIVERSITY   (China)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Bcr Abl; Chronic myelogenous leukemia; Real time RT PCR; WT 1

Indexed keywords

BCR ABL PROTEIN; BIOLOGICAL MARKER; COMPLEMENTARY DNA; OLIGONUCLEOTIDE; WT1 PROTEIN;

ADULT; AGED; ANALYTICAL EQUIPMENT; ARTICLE; BONE MARROW CELL; CELLULAR DISTRIBUTION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MINIMAL RESIDUAL DISEASE; MOLECULAR CLONING; PATIENT MONITORING; PHILADELPHIA 1 CHROMOSOME; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; GENES, ABL; GENES, WILMS TUMOR; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED; NEOPLASM, RESIDUAL; PHILADELPHIA CHROMOSOME; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 4344696570     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Chen ZX. The possible role and application of WT-1 in human leukemia. Int J Hematol 2001;73:39-46.
2. Brieger J, Weidmann E, Fenchel K, et al. The expression of the Wilm's tumor gene in acute myelocytic leukemias as a possible marker for leukemic blast cells. Leukemia 1994;8: 2138-2143.
3. Inoue K, Sugiyama H, Ogawa H, et al. WT-1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood 1994;84: 3071-3979.
4. Menssen HD, Renkl HJ, Rodeck U, et al. Presence of Wilms' tumor gene (wtl) transcripts and the WT-1 nuclear protein in the majority of human acute leukemias. Leukemia 1995;9:1060-1067.
5. Bergmann L, Miething C, Maurer U, et al. High levels of Wilms' tumor gene (wtl) mRNA in acute myeloid leukemias are associated with a worse long-term outcome. Blood 1997; 90:1217-1225.
6. Schmid D, Heinze G, Linnerth B, et al. Prognostic significance of WT-1 gene expression at diagnosis in adult de novo acute myeloid leukemia. Leukemia 1997;11:639-643.
7. + progenitors and downregulated early in the course of differentiation in vitro. Exp Hematol 1997;25:945-950.
8. Gaiger A, Schmid D, Heinze G, et al. Detection of the WT1 transcript by RT-PCR in complete remission has no prognostic relevance in de novo acute myeloid leukemia. Leukemia 1998;12:1886-1894.
9. Trka J, Kalinova M, Hrusak O, et al. Real-time quantitative PCR detection of WT1 gene expression in children with AML: prognostic significance, correlation with disease status and residual disease detection by flow cytometry. Leukemia 2002; 16:1381-1389.
10. Cilloni D, Gottardi E, De Micheli D, et al. Quantitative assessment of WT-1 expression by real-time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients. Leukemia 2002;16:2115-2121.
11. Cilloni D, Saglio G. Usefulness of quantitative assessment of WT-1 expression in CML patients undergoing Imatinib therapy. Semin in Hematol 2002;40(suppl):37-41.